Y Intercept Hong Kong Ltd Makes New $213,000 Investment in AngioDynamics, Inc. (NASDAQ:ANGO)

Y Intercept Hong Kong Ltd purchased a new stake in AngioDynamics, Inc. (NASDAQ:ANGO) in the first quarter, HoldingsChannel reports. The fund purchased 22,671 shares of the medical instruments supplier’s stock, valued at approximately $213,000.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in ANGO. Quinn Opportunity Partners LLC purchased a new position in shares of AngioDynamics in the fourth quarter worth $92,000. ProShare Advisors LLC acquired a new stake in AngioDynamics in the 4th quarter worth about $100,000. Graham Capital Management L.P. purchased a new position in AngioDynamics in the 4th quarter valued at $106,000. OneDigital Investment Advisors LLC lifted its stake in AngioDynamics by 14.0% in the 4th quarter. OneDigital Investment Advisors LLC now owns 12,137 shares of the medical instruments supplier’s stock worth $111,000 after purchasing an additional 1,490 shares in the last quarter. Finally, Cerity Partners LLC grew its position in AngioDynamics by 22.0% in the first quarter. Cerity Partners LLC now owns 12,929 shares of the medical instruments supplier’s stock worth $121,000 after acquiring an additional 2,333 shares during the period. Hedge funds and other institutional investors own 89.43% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts have recently issued reports on ANGO shares. HC Wainwright reaffirmed a “buy” rating and set a $16.00 price objective on shares of AngioDynamics in a research report on Wednesday, July 16th. Lake Street Capital started coverage on shares of AngioDynamics in a report on Wednesday, July 16th. They issued a “buy” rating and a $24.00 target price for the company. Finally, Canaccord Genuity Group lifted their price objective on shares of AngioDynamics from $15.00 to $17.00 and gave the company a “buy” rating in a research note on Wednesday, July 16th.

AngioDynamics Stock Down 1.8%

Shares of ANGO stock opened at $8.96 on Thursday. The business’s 50 day moving average is $9.80 and its two-hundred day moving average is $9.99. The company has a market cap of $364.04 million, a PE ratio of -10.80 and a beta of 0.60. AngioDynamics, Inc. has a 12 month low of $5.83 and a 12 month high of $13.50.

AngioDynamics (NASDAQ:ANGO) last released its quarterly earnings data on Tuesday, July 15th. The medical instruments supplier reported ($0.03) EPS for the quarter, topping analysts’ consensus estimates of ($0.12) by $0.09. AngioDynamics had a negative net margin of 11.62% and a negative return on equity of 3.20%. The company had revenue of $80.16 million during the quarter, compared to the consensus estimate of $74.26 million. During the same period last year, the firm earned ($0.06) EPS. The firm’s revenue for the quarter was up 13.0% compared to the same quarter last year. As a group, equities analysts expect that AngioDynamics, Inc. will post -0.37 EPS for the current fiscal year.

AngioDynamics Company Profile

AngioDynamics, Inc, a medical technology company, engages in the design, manufacture, and sale of medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. The company offers Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium.